# Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India

> **NCT03777865** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 100 (actual)

## Conditions studied

- Vaccines

## Interventions

- **BIOLOGICAL:** 13vPnC

## Key facts

- **NCT ID:** NCT03777865
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-14
- **Primary completion:** 2019-04-17
- **Final completion:** 2019-04-17
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03777865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03777865, "Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03777865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*